Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000259 · ClinicalTrials.gov registry record · NA
Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00000259 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 12 participants.
The verdict
NCT00000259, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. Comparisons between nitrous oxide, opiates, and benzodiazepine antagonists will be made. To examine sevoflurane versus isoflurane inhalation at subanesthetic concentrations on mood, pain, and psychomotor performance.
Interventions
- OTHER Placebo
- DRUG 15 % Nitrous oxide
- DRUG 0.3 % Sevoflurane
- DRUG 30% Nitrous oxide
- DRUG 0.6% Sevoflurane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 1996-08 |
| Est. Completion | 1997-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000259
The ClinicalTrials.gov registry entry for NCT00000259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00000259 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000259 about?
NCT00000259 is a clinical study titled "Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11". The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. Comparisons between nitrous oxide, opiate...
What is the current status of trial NCT00000259?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 1996-08. Estimated completion is 1997-11.
What interventions are being tested in trial NCT00000259?
The interventions under investigation include: Placebo (OTHER), 15 % Nitrous oxide (DRUG), 0.3 % Sevoflurane (DRUG), 30% Nitrous oxide (DRUG), 0.6% Sevoflurane (DRUG).
Who is sponsoring clinical trial NCT00000259?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.